Home / Japan / J-Pharma Co.,Ltd.
J-Pharma Co.,Ltd.
Short position disclosed on October 16, 2026.
1.83% of the capital sold short
2 disclosing funds
35 disclosures on record
Evolution of the disclosed total
0%1%2%3%4%
Sep 11Sep 20Sep 29Oct 8Oct 17
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| モルガン・スタンレーmufg証券株式会社 | 1.14% | new | October 16, 2026 | |
| Nomura International plc | 0.69% | -0.09 pt | October 15, 2026 |
Get the moves on J-Pharma Co.,Ltd. by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
Download 35 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Japan
- Towa Corporation 15.00% of the capital sold short
- ReYuu Japan Inc. 12.82% of the capital sold short
- Metaplanet Inc. 12.01% of the capital sold short
- Datasection Inc. 10.47% of the capital sold short
- Kasumigaseki Capital Co.,Ltd. 9.57% of the capital sold short
- KLab Inc. 9.55% of the capital sold short
- Skyfall Inc. 9.44% of the capital sold short
- QD Laser,Inc. 9.23% of the capital sold short
- ERTH Group Co.,Ltd. 9.05% of the capital sold short
- Dynamic Map Platform Co.,Ltd. 8.68% of the capital sold short
- Kitagawa Seiki Co.,ltd. 7.84% of the capital sold short
- akippa Inc. 7.64% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, J-Pharma Co.,Ltd., source JPX, data as at October 16, 2026, https://www.quivad.com/action/j-pharma-co-ltd